Moderna, Inc.

MRNA · Healthcare · · USD

52.88 USD

0.00 (-2.70%)

● Updated 2026-05-12 11:49 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score STRONG BUY Mid-term (Position)

/ 100

Technical 100

Trend & RS 83

Momentum 93

Fundamental 67

Macro 65

Liquidity 83

Component	Score	Weight
Technical	100.0	20%
Trend & RS	83.0	30%
Momentum	93.2	15%
Fundamental	66.7	10%
Macro	65.1	20%
Liquidity	83.2	5%

Trade Setup

Entry	52.88
Stop Loss	45.48 (14.0%)
Target 1 (1:1)	60.28 (+14.0%)
Target 2 (2:1)	67.68 (+28.0%)

ATR(14)	3.70 (7.0%)
Risk per Share	7.40
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	79.9	+1.20
Momentum	84.7	+1.39
Quality	18.2	-1.27
Composite	60.9

Quality Scores

Piotroski F-Score 3 /9 — Weak

✗ ✗ ✗ ✗ ✓ ✓ ✗ ✗ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score 10.62 — Safe Zone

Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Undervalued

Metric	Stock	Sector	vs Peers
P/E Ratio	N/A	22.0	Inline
P/B Ratio	2.4	4.0	Below

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

52.99%

Full Kelly

26.5%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 83/100. Estimated win rate 65%, avg win 10.0%, avg loss 3.3%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

56.47

RSI(14)

-0.2654

MACD

Relative Strength (RS) WEAKENING

/ 99

RS Rating

✓ O'Neil PASS (≥80)

RS vs SPY	↓ FALLING (+19.2% vs SPY 3M)
RS vs Sector	OUTPERFORMING (Healthcare)
RS New High	No (47d since high)
Sector Outperformance	+28.6% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

WEAKENING: Losing momentum — the stock was performing well but is now falling behind the market.

Technical Indicators

Indicator	Value	Signal
Rsi	56.47	NEUTRAL
Macd	-0.2654	BULLISH
Ma Cross	51.58 / 36.22	GOLDEN CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	3.25x	HIGH

Key Levels

Level	Price
52-Week High	59.55
Bollinger Upper	57.93
SMA(200)	36.22
SMA(50)	51.58
SMA(20)	50.75
Current Price	52.88
Bollinger Lower	43.57
52-Week Low	22.28
ATR(14)	3.7

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

DISTRIBUTION C Confidence

56%

Upthrust (potential)

Acc: 0.0 | Dist: 2.5 | Markup: 2.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-05-05	Normal	0.62x	Normal bar — no special VSA pattern
2026-05-06	No Supply	0.56x	Low volume, narrow spread, firm close — no selling pressure
2026-05-07	Normal	1.09x	Normal bar — no special VSA pattern
2026-05-08	Normal	2.68x	Normal bar — no special VSA pattern
2026-05-11	Stopping Volume	3.25x	High volume down-bar closing near low — potential climax (Stopping Volume)

Ichimoku Cloud NEUTRAL

Line	Value	Status
Tenkan-sen (9)	51.58	Below Kijun
Kijun-sen (26)	51.58	Base line
Senkou A	51.58	Leading span A
Senkou B	51.61	Leading span B
Cloud	51.58 – 51.61	Bearish (Red)
Price vs Cloud	52.88	Above Cloud
Chikou Span	48.77	Bullish
Alignment Score	2/4	NEUTRAL